UroMems

UroMems develops innovative, implantable mechatronics technology to treat stress urinary incontinence (SUI). Their flagship product, UroActive, is a smart automated artificial urinary sphincter designed to improve patient outcomes and address unmet needs in SUI treatment. The technology is protected by over 150 patents.

Funding Round: Series C

Funding Amount: $47M

Date: 25-Jun-2024

Investors: Crédit Mutuel Innovation, European Innovation Council, Wellington Partners, Bpifrance, Supernova Invest, Hil-Invent, b-to-v Partners, Financière Arbevel

Markets: Medtech, Healthtech

HQ: Grenoble, Auvergne-Rhône-Alpes, France

Founded: 2011

Website: https://www.uromems.com

LinkedIn: https://www.linkedin.com/company/uromems/

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/uromems

Pitchbook: https://pitchbook.com/profiles/company/168192-10